title: Metabolic effects of FK 506 (tacrolimus) versus cyclosporine in portally drained pancreas allografts.
authors.affiliation: Department of Surgery, University of Tennessee, Memphis 38163, USA.
authors.forename: D S
authors.initials: DS
authors.lastname: Elmer
authors.forename: A B
authors.initials: AB
authors.lastname: Abdulkarim
authors.forename: D
authors.initials: D
authors.lastname: Fraga
authors.forename: H
authors.initials: H
authors.lastname: Shokouh-Amiri
authors.forename: R J
authors.initials: RJ
authors.lastname: Stratta
authors.forename: D K
authors.initials: DK
authors.lastname: Hathaway
authors.forename: K
authors.initials: K
authors.lastname: Reddy
authors.forename: A O
authors.initials: AO
authors.lastname: Gaber
mesh_terms: D016572:Cyclosporine / Q000008:administration & dosage*; D048909:Diabetes Complications; D003920:Diabetes Mellitus / Q000378:metabolism / Q000601:surgery*; D004322:Drainage; D005260:Female; D005947:Glucose / Q000378:metabolism*; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D006943:Hyperglycemia / Q000209:etiology / Q000517:prevention & control; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D016035:Pancreas Transplantation; D011168:Portal System / Q000601:surgery; D016559:Tacrolimus / Q000008:administration & dosage*; D014184:Transplantation, Homologous
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine; D005947:Glucose; D016559:Tacrolimus